by evommune | Dec 4, 2023
Kyle Carver serves as Chief Financial Officer of Evommune. Prior to Evommune, Kyle served as Chief Accounting Officer at Kadmon, a Sanofi Company, where he oversaw all aspects of financial and accounting operations, including Kadmon’s transition to a public company in...
by evommune | Dec 4, 2023
Gregory S. Moss serves as Chief Business and Legal Officer, as well as Corporate Secretary and Chief Compliance Officer of Evommune. Prior to Evommune, Greg served as Executive Vice President, General Counsel, and Corporate Secretary, Chief Compliance Officer at...
by evommune | Dec 4, 2023
Dr. Jeegar Patel is Chief Scientific Officer at Evommune. Prior to Evommune, Jeegar served as Senior Vice President, Research and Nonclinical Development at Kadmon, a Sanofi Company, where he held positions of increasing responsibility and led the research and...
by evommune | Dec 4, 2023
Janice Drew has over 30 years of experience in clinical development covering early-stage research, Phase 1 through Phase 3 clinical trials, and development activities through the commercialization and life-cycle–management phase of a product. Janice’s expertise lies...
by evommune | Dec 4, 2023
Dr. Lou Sehl has more than 30 years of experience in the biotechnology, pharmaceutical, and medical device industries, with a consistent track record of success moving projects through all phases of development. Prior to Evommune, he was Vice President of...
